FDA Inspection 1225737 — University of Pittsburgh Cancer Institute Cancer Service
The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on December 12, 2023 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Erie, PA (United States)